Monitoring Activity And Gait In Children (MAGIC)

Pfizer

Status: Completed

Conditions: Child; Child, Preschool; Adolescent

Treatments: Device: Panoramic Bracelet and GENEActiv; Device: COHORT A: Actigraph

Study type: Observational

Funder types: Industry

Identifiers

NCT04823650

X9001263

MAGIC (Other Identifier)

Details and patient eligibility

About

COHORT A: To study whether a digital health tool called Actigraph can be used to collect information on gait and physical activity in healthy children aged 3-17. The study will be conducted at the Pfizer Innovation Research Laboratory (PfIRe Lab) in Cambridge MA. In the lab at the first visit, we will ask participants to do activities such as walking on different surfaces as well as to roll a dice and move between different activity stations. Children will wear 2 Actigraph devices, one as a watch and one as a belt. They will then go home and do usual daily activities while answering a brief daily activity diary for approximately 2 weeks. The conclusion of the study will be over the telephone and include questions on the comfort and wearability of the device. The analysis of gait and physical activity as well as adherence and wearability will be looked across three different age groups 3-5, 6-11, and 12-17.

COHORT B: Cohort B of the study aims to evaluate the feasibility of the Panoramic Bracelet and associated algorithms such as SleepPy and GaitPy compared to the GENEActiv device and to evaluate the comfort and wearability of the Panoramic Bracelet. The results of this study will enable the use of novel devices in future clinical trials measuring scratch and sleep. . In the lab at the first visit, we will ask participants to do activities such as walking on different surfaces as well as to roll a dice and move between different activity stations. They will then go home and do usual daily activities while wearing both devices in the same wrist at different times stipulated in the protocol, answering a brief daily activity and sleep diary for approximately 2 weeks. Cohort B includes questions on the comfort and wearability of the Panoramic device on Day 7 approximately. The conclusion of the study will be over the telephone.The analysis will be looked across three different age groups 3-5, 6-11, and 12-17

Enrollment: 87 patients

Sex: All

Ages: 3 to 17 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Ambulatory
• No significant health problems that would impair the completion of the physical activity tasks, does not carry any diagnosis of developmental delay and/or significant co-morbid medical conditions as determined by a medically qualified individual during medical history review

Exclusion criteria

• Participation in other studies involving digital devices within 1 week and/or treatment with an investigational drug (Phases 1-4) within 30 days or 5 half-lives before the current study begins and/or during study participation.
• Participants with implanted medical devices.
• Minor participants who reach the age of majority during the study, as recognized under local law.
• Any medical or psychiatric condition that may increase the risk of study participation or, in the investigator's judgment, make the participant inappropriate for the study.
• Participants with known allergies to components as specified by device manufacturer if applicable (eg, plastic, stainless steel and silicone).

Trial design

87 participants in 3 patient groups

Ages 3-5

Description:

COHORT A and B

Treatment:

Device: COHORT A: Actigraph

Device: Panoramic Bracelet and GENEActiv

Ages 6-11

Description:

COHORT A and B

Treatment:

Device: COHORT A: Actigraph

Device: Panoramic Bracelet and GENEActiv

Ages 12-17

Description:

COHORT A and B

Treatment:

Device: COHORT A: Actigraph

Device: Panoramic Bracelet and GENEActiv